| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
66,714 |
61,142 |
$3.24M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
31,018 |
27,948 |
$1.95M |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
7,634 |
7,270 |
$1.68M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
21,387 |
9,780 |
$780K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,370 |
7,163 |
$493K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
5,782 |
5,009 |
$475K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
2,562 |
2,433 |
$455K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
4,212 |
2,516 |
$344K |
| 99480 |
Subsequent intensive care, per day, low birth weight infant |
3,147 |
813 |
$276K |
| 99222 |
Initial hospital care, per day, moderate complexity |
3,018 |
2,746 |
$232K |
| 99479 |
Subsequent intensive care, per day, very low birth weight infant |
2,527 |
557 |
$218K |
| 59400 |
Routine obstetric care including antepartum care, vaginal delivery, and postpartum care |
123 |
120 |
$185K |
| 99469 |
Subsequent inpatient neonatal critical care, per day, 28 days or younger |
618 |
171 |
$158K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,653 |
4,556 |
$148K |
| 99223 |
Prolong inpt eval add15 m |
1,678 |
1,605 |
$142K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,649 |
1,548 |
$140K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
2,862 |
2,721 |
$136K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
5,308 |
2,537 |
$129K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
2,106 |
2,008 |
$95K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,770 |
5,635 |
$85K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,638 |
1,597 |
$76K |
| 11721 |
|
2,594 |
2,447 |
$76K |
| 87428 |
|
2,219 |
2,178 |
$69K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
524 |
504 |
$64K |
| 99215 |
Prolong outpt/office vis |
746 |
714 |
$62K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,454 |
1,415 |
$53K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
841 |
394 |
$52K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,538 |
1,743 |
$52K |
| 99233 |
Prolong inpt eval add15 m |
873 |
649 |
$44K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
509 |
502 |
$43K |
| 73630 |
|
998 |
742 |
$24K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
226 |
223 |
$22K |
| 90686 |
|
1,230 |
1,205 |
$18K |
| 95251 |
|
732 |
693 |
$12K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
106 |
106 |
$11K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
180 |
140 |
$11K |
| 76821 |
|
130 |
75 |
$11K |
| 90715 |
|
323 |
318 |
$10K |
| 99205 |
Prolong outpt/office vis |
106 |
104 |
$10K |
| 76820 |
|
135 |
78 |
$9K |
| 11056 |
|
405 |
390 |
$8K |
| 99468 |
|
12 |
12 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
754 |
716 |
$6K |
| 76801 |
|
49 |
49 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
873 |
846 |
$5K |
| J3490 |
Unclassified drugs |
53 |
53 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
158 |
157 |
$4K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
27 |
13 |
$3K |
| 85018 |
|
1,403 |
1,368 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
26 |
25 |
$3K |
| 90870 |
|
89 |
26 |
$3K |
| 76827 |
|
34 |
29 |
$2K |
| 96127 |
|
81 |
78 |
$2K |
| 76825 |
|
12 |
12 |
$2K |
| 76830 |
Ultrasound, transvaginal |
20 |
20 |
$2K |
| 87807 |
|
130 |
125 |
$2K |
| 99221 |
|
42 |
40 |
$1K |
| 81003 |
|
826 |
779 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
94 |
93 |
$1K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
42 |
37 |
$1K |
| 90656 |
|
46 |
45 |
$608.64 |
| 81025 |
|
57 |
54 |
$466.64 |
| 36415 |
Collection of venous blood by venipuncture |
110 |
104 |
$411.50 |
| 71046 |
Radiologic examination, chest; 2 views |
12 |
12 |
$353.80 |
| 73610 |
|
15 |
13 |
$341.82 |
| 11719 |
|
12 |
12 |
$137.70 |
| 0502F |
|
10,416 |
7,329 |
$96.68 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
56 |
49 |
$90.24 |
| 81002 |
|
25 |
25 |
$80.46 |
| 0500F |
|
224 |
218 |
$0.51 |
| 0503F |
|
27 |
26 |
$0.09 |
| 3078F |
|
30 |
26 |
$0.00 |
| 36416 |
|
138 |
135 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
13 |
13 |
$0.00 |
| 3074F |
|
15 |
13 |
$0.00 |